Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 81,672 | 96,633 | 74,859 | 54,917 | 42,443 |
| Cost of Goods | 33,794 | 40,328 | 31,469 | 20,699 | 16,535 |
| Gross Profit | 47,878 | 56,305 | 43,390 | 34,218 | 25,908 |
| Operating Expenses | 95,402 | 114,301 | 109,965 | 74,215 | 38,454 |
| Operating Income | -46,730 | -57,668 | -66,106 | -39,298 | -12,011 |
| Interest Expense | 10,429 | 8,761 | 4,554 | 3,115 | 2,723 |
| Other Income | 1,940 | 3,146 | 142 | -662 | -1,930 |
| Pre-tax Income | -55,219 | -63,283 | -70,518 | -43,075 | -16,664 |
| Income Tax | 146 | 40 | 123 | -140 | 42 |
| Net Income Continuous | -55,365 | -63,323 | -70,641 | -42,935 | -16,706 |
| Net Income | $-55,365 | $-63,323 | $-70,641 | $-42,935 | $-16,706 |
| EPS Basic Total Ops | -1.12 | -1.43 | -1.87 | -1.65 | -9.18 |
| EPS Basic Continuous Ops | -1.12 | -1.43 | -1.87 | -1.60 | -7.05 |
| EPS Diluted Total Ops | -1.12 | -1.43 | -1.87 | -1.65 | -9.18 |
| EPS Diluted Continuous Ops | -1.12 | -1.43 | -1.87 | -1.60 | -7.05 |
| EPS Diluted Before Non-Recurring Items | -0.96 | -1.43 | -1.87 | -1.64 | N/A |
| EBITDA(a) | $-39,076 | $-48,778 | $-58,957 | $-34,506 | $-8,196 |